tiprankstipranks
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX
US Market

Accelerate Diagnostics (AXDX) Income Statement

Compare
300 Followers

Accelerate Diagnostics Income Statement

Last quarter (Q3 2024), Accelerate Diagnostics's total revenue was $2.98M, a decrease of -9.82% from the same quarter last year. In Q3, Accelerate Diagnostics's net income was $-14.64M. See Accelerate Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 12.06M$ 12.75M$ 11.78M$ 11.16M$ 9.30M
Gross Profit
$ 2.55M$ 3.30M$ -381.00K$ 4.46M$ 4.40M
Operating Expenses
$ 56.58M$ 66.11M$ 71.18M$ 68.16M$ 77.23M
Depreciation and Amortization
$ 3.25M$ 3.00M$ 2.52M$ 3.00M$ 2.60M
EBITDA
$ -49.77M$ -55.80M$ -59.59M$ -59.66M$ -67.56M
Operating Income
$ -54.03M$ -62.80M$ -71.56M$ -63.70M$ -72.83M
Other Income/Expenses
$ -6.74M$ 235.00K$ -6.10M$ -14.50M$ -11.59M
Pretax Income
$ -60.77M$ -62.57M$ -77.66M$ -78.20M$ -84.42M
Net Income
$ -61.62M$ -62.49M$ -77.70M$ -78.21M$ -84.31M
Per Share Metrics
Basic EPS
$ -4.94$ -7.61$ -12.59$ -13.96$ -15.47
Diluted EPS
$ -4.94$ -7.61$ -12.59$ -13.96$ -15.47
Weighted Average Shares Outstanding
12.48M 8.22M 6.17M 5.60M 5.45M
Weighted Average Shares Outstanding (Diluted)
12.48M 8.22M 6.17M 5.60M 5.45M
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis